A detailed history of Sg Americas Securities, LLC transactions in Entrada Therapeutics, Inc. stock. As of the latest transaction made, Sg Americas Securities, LLC holds 9,745 shares of TRDA stock, worth $171,414. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9,745
Holding current value
$171,414
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 03, 2024

BUY
$13.65 - $17.86 $133,019 - $174,045
9,745 New
9,745 $156,000
Q1 2024

May 06, 2024

SELL
$11.58 - $17.0 $46,632 - $68,459
-4,027 Reduced 34.38%
7,687 $109,000
Q4 2023

Jan 12, 2024

BUY
$11.36 - $16.99 $28,854 - $43,154
2,540 Added 27.69%
11,714 $177,000
Q3 2023

Oct 13, 2023

BUY
$13.61 - $18.01 $124,858 - $165,223
9,174 New
9,174 $145,000

Others Institutions Holding TRDA

About Entrada Therapeutics, Inc.


  • Ticker TRDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,368,500
  • Market Cap $552M
  • Description
  • Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal escape vehicle platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs. The company's lead product candidate is ENTR-601-44, which is in precli...
More about TRDA
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.